Apogee Therapeutics(APGE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APGE Apogee Therapeutics

交易中 11-26 09:34:08 EST

43.90

+0.05

+0.11%

最高44.41	最低43.48	成交量8,955
今开44.11	昨收43.85	日振幅2.12%
总市值24.98亿	流通市值12.07亿	总股本5,690万
成交额39.31万	换手率0.03%	流通股本2,749万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"APGE","market":"US","secType":"STK","nameCN":"Apogee Therapeutics","latestPrice":43.8962,"timestamp":1732631624127,"preClose":43.85,"halted":0,"volume":8955,"delay":0,"floatShares":27492401,"shares":56902910,"eps":-2.768283,"marketStatus":"交易中","marketStatusCode":2,"change":0.0462,"latestTime":"11-26 09:34:08 EST","open":44.11,"high":44.41,"low":43.48,"amount":393067.18799999997,"amplitude":0.021209,"askPrice":43.81,"askSize":123,"bidPrice":43.5,"bidSize":135,"shortable":3,"etf":0,"ttmEps":-2.768283,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732654800000},"adr":0,"listingDate":1689307200000,"adjPreClose":43.85,"preHourTrading":{"tag":"盘前","latestPrice":44.65,"preClose":43.85,"latestTime":"09:26 EST","volume":6,"amount":267.69,"timestamp":1732631199357},"postHourTrading":{"tag":"盘后","latestPrice":43.8484,"preClose":43.85,"latestTime":"16:20 EST","volume":29033,"amount":1273081.3888,"timestamp":1732569603849},"volumeRatio":1.459594,"impliedVol":0.6268,"impliedVolPercentile":0.48},"requestUrl":"/m/hq/s/APGE/wiki","defaultTab":"wiki","newsList":[{"id":"2486704569","title":"美国研究综述-Allstate、Mongodb、Primerica","url":"https://stock-news.laohu8.com/highlight/detail?id=2486704569","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486704569?lang=zh_cn&edition=full","pubTime":"2024-11-26 14:38","pubTimestamp":1732603125,"startTime":"0","endTime":"0","summary":"美国研究综述-Allstate、Mongodb、Primerica路透社11月26日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Allstate、Mongodb 和 Primerica。公司要闻 * 安捷伦科技公司A.N：摩根大通将其目标价从165美元下调至160美元 * Allstate Corp ALL.N：Piper Sandler将目标价从206美元上调至244美元 * Mongodb Inc MDB.O：Piper Sandler将目标价从335美元上调至425美元 * Primerica Inc PRI.N：TD Cowen将目标价从314美元上调至345美元 * UnitedHealth UNH.N：RBC 将目标价从 595 美元上调至 655 美元以下是路透社周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nL3S3MX0IA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNH","PRI","HBBD.SI","OKE","LU2097828474.EUR","RNA","GDRX","LU0831103253.SGD","MBIN","LU0501845795.SGD","LESL","LU0823038988.USD","09988","LU0545039389.USD","LU1223082519.USD","LU2087589342.USD","NEM","ONB","CENT","SG9999014906.USD","SMTC","89988","DYN","IE000M9KFDE8.USD","LU1152091168.USD","LU0823413660.USD","BABA","ENTA","HK0000320223.HKD","LU0029874905.USD","A","LU0499858438.USD","LU0788108826.HKD","LU0918141705.HKD","LU0648948544.HKD","BBWI","LU2324357040.USD","SUM","ALEC","APGE","ALL","LU0234572021.USD","TDOC","MDB","LU2413666426.HKD","SNDR","COLM","LU0132412106.USD"],"gpt_icon":1},{"id":"2486705257","title":"单月超6亿美元，医药企业IPO规模重返疫情前水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2486705257","media":"财通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486705257?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:34","pubTimestamp":1732527240,"startTime":"0","endTime":"0","summary":"今年以来，生物医药领域已经有30家公司IPO上市，累计融资规模超40.49亿美元，其中不乏CG Oncology、Kyverna Therapeutics等IPO规模超3亿美元的公司。在多肽类PTH1R激动剂领域，阿斯利康以总价18亿美元收购AmolytPharma，获得了处于临床3期的PTH1R激动剂eneboparatide，目前该疗法已经获得了FDA快速通道认定，另一家药企AscendisPharma的Yorvipath获得FDA批准上市，用于治疗成人慢性甲状旁腺功能减退。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-25/doc-incxhqmk8147031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PSQ","TSLP","GLYC","BDMD","SYRS","MNQmain",".IXIC","OMGA","NQmain","BK4561","UPB","SQQQ","TQQQ","BK4539","GPCR","ASO","BK4007","BK4599","SEPN","BK4082","QID","BK4200","QLD","BK4020","CAMP","APGE","BK4139","AVTE"],"gpt_icon":1},{"id":"2483801003","title":"Apogee Therapeutics, Inc.盘中异动 早盘股价大跌5.17%报50.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483801003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483801003?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:39","pubTimestamp":1731595180,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时39分，Apogee Therapeutics, Inc.股票出现异动，股价快速跳水5.17%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223940971a6906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223940971a6906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APGE","LENZ"],"gpt_icon":0},{"id":"2483034407","title":"Apogee Therapeutics, Inc.盘中异动 股价大跌5.16%报57.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483034407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483034407?lang=zh_cn&edition=full","pubTime":"2024-11-13 02:01","pubTimestamp":1731434493,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日02时01分，Apogee Therapeutics, Inc.股票出现异动，股价快速跳水5.16%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113020134a23126d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113020134a23126d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APGE","BK4139"],"gpt_icon":0},{"id":"2482487081","title":"Apogee Therapeutics, Inc.盘中异动 大幅拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482487081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482487081?lang=zh_cn&edition=full","pubTime":"2024-11-09 01:02","pubTimestamp":1731085356,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日01时02分，Apogee Therapeutics, Inc.股票出现波动，股价快速拉升5.13%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110901023698e41893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110901023698e41893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APGE"],"gpt_icon":0},{"id":"2480583262","title":"Apogee Therapeutics, Inc.盘中异动 下午盘急速拉升5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480583262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480583262?lang=zh_cn&edition=full","pubTime":"2024-11-02 01:03","pubTimestamp":1730480590,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日01时03分，Apogee Therapeutics, Inc.股票出现异动，股价快速上涨5.57%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201031098e400f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110201031098e400f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APGE"],"gpt_icon":0},{"id":"2479803457","title":"Apogee Therapeutics, Inc.盘中异动 早盘股价大跌5.04%报52.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479803457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479803457?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:53","pubTimestamp":1730386387,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时53分，Apogee Therapeutics, Inc.股票出现波动，股价快速跳水5.04%。截至发稿，该股报52.14美元/股，成交量9.5611万股，换手率0.17%，振幅4.60%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.42%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031225307971a3963&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031225307971a3963&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APGE","LENZ"],"gpt_icon":0},{"id":"2478448614","title":"Apogee Therapeutics, Inc.盘中异动 股价大涨5.17%报55.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478448614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478448614?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:40","pubTimestamp":1730122855,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时40分，Apogee Therapeutics, Inc.股票出现异动，股价快速拉升5.17%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214055a1f25200&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214055a1f25200&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APGE","BK4139"],"gpt_icon":0},{"id":"2476230725","title":"Apogee Therapeutics, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476230725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476230725?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:36","pubTimestamp":1729258580,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时36分，Apogee Therapeutics, Inc.股票出现异动，股价急速下跌5.30%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018213621ab6b2e9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018213621ab6b2e9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APGE","BK4139"],"gpt_icon":0},{"id":"2475687105","title":"Apogee Therapeutics, Inc.盘中异动 早盘急速下挫5.00%报53.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475687105","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475687105?lang=zh_cn&edition=full","pubTime":"2024-10-15 22:38","pubTimestamp":1729003090,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日22时38分，Apogee Therapeutics, Inc.股票出现异动，股价大幅下跌5.00%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015223811971a066f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015223811971a066f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APGE","BK4139"],"gpt_icon":0},{"id":"2470257192","title":"Apogee Therapeutics, Inc.盘中异动 大幅跳水5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470257192","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470257192?lang=zh_cn&edition=full","pubTime":"2024-09-25 21:30","pubTimestamp":1727271048,"startTime":"0","endTime":"0","summary":"北京时间2024年09月25日21时30分，Apogee Therapeutics, Inc.股票出现异动，股价快速下挫5.74%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092521304898e38ddd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092521304898e38ddd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APGE","LENZ"],"gpt_icon":0},{"id":"2468962134","title":"Apogee Therapeutics, Inc.盘中异动 股价大涨5.39%报55.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468962134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468962134?lang=zh_cn&edition=full","pubTime":"2024-09-20 22:04","pubTimestamp":1726841069,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日22时04分，Apogee Therapeutics, Inc.股票出现波动，股价大幅上涨5.39%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.77%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920220429a1db7562&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920220429a1db7562&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APGE","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apogeetherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0326},{"period":"1month","weight":-0.1762},{"period":"3month","weight":-0.0774},{"period":"6month","weight":-0.0294},{"period":"1year","weight":1.5494},{"period":"ytd","weight":0.5694}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0319},{"period":"3month","weight":0.0641},{"period":"6month","weight":0.1358},{"period":"1year","weight":0.3124},{"period":"ytd","weight":0.2571}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Apogee Therapeutics, Inc.于2023年6月9日作为一家特拉华州公司成立，与此次发行有关，作为一家控股公司，将全资拥有Apogee Therapeutics，LLC，并间接拥有其子公司。该公司是一家生物技术公司，致力于开发用于治疗特应性皮炎、慢性阻塞性肺病及相关炎症和免疫学适应症的差异化生物制剂，这些适应症的需求尚未得到满足。该公司的抗体项目旨在克服现有疗法的局限性，针对的是成熟的作用机制，并结合先进的抗体工程来优化半衰期和其他特性。","exchange":"NASDAQ","name":"Apogee Therapeutics","nameEN":"Apogee Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apogee Therapeutics(APGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apogee Therapeutics(APGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apogee Therapeutics,APGE,Apogee Therapeutics股票,Apogee Therapeutics股票老虎,Apogee Therapeutics股票老虎国际,Apogee Therapeutics行情,Apogee Therapeutics股票行情,Apogee Therapeutics股价,Apogee Therapeutics股市,Apogee Therapeutics股票价格,Apogee Therapeutics股票交易,Apogee Therapeutics股票购买,Apogee Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apogee Therapeutics(APGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apogee Therapeutics(APGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}